Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kv1.5 is a voltage-gated potassium channel subunit that forms homotetrameric or heterotetrameric channels in the cell membrane. It plays a crucial role in the repolarization of atrial action potentials and contributes to the ultrarapid delayed rectifier current (IKur) in the heart. Kv1.5 also regulates vascular tone in pulmonary arteries and influences insulin secretion in pancreatic beta cells. Mutations and dysregulation of Kv1.5 have been linked to atrial fibrillation, sudden cardiac death, and pulmonary hypertension.
Channel blockade (for blockers); Modulation of channel expression/activity via kinases (PKC, PKA)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel protein Kv1.5 subunit (Kv1.5).